New York University

A patent infringement suit filed by New York University and Centocor, Inc., against Abbott Laboratories remains pending. The suit asserts that adalimumab — a drug Abbott sells under the trademark…

A case is pending against Abbott Laboratories in the Eastern District of Texas, in which New York University (NYU) and Centocor, Inc. assert that Humira(R) infringes a patent co-owned by…